News

PRESS MENTIONS
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
30 Sep 2024
Read More
Owlstone Medical Appoints Mark Capone to Board of Directors
Owlstone Medical Appoints Mark Capone to Board of Directors
Read More
16 Sep 2021
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Read More
7 Sep 2021
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Read More
20 Jul 2021
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Read More
18 May 2021
Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
Read More
19 Jan 2021
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Read More
22 Sep 2020
DRAGON: A new international project funded by IMI and supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation to develop a diagnostics tool combatting coronavirus infections.
DRAGON: A new international project funded by IMI and supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation to develop a diagnostics tool combatting coronavirus infections.
Read More
13 May 2020
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Read More
30 Mar 2020
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Read More
9 Mar 2020
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure
Read More
10 Dec 2019
Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy
Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy
Read More
7 Nov 2019
Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases
Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases
Read More
29 Oct 2019
Previous
1 2 3 4 5 6 … 8
Next

Talk to us about your biomarker research and how Breath Biopsy could help.

contact us